Northwest Biotherapeutics reported $200K in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Agenus USD 34.2M 3.97M Dec/2025
AstraZeneca USD 15.29B 213M Mar/2026
Bristol-Myers Squibb USD 11.49B 1.01B Mar/2026
Celldex Therapeutics USD 15K 106K Mar/2026
Eisai JPY 205.43B 14.51B Mar/2026
Infinity Pharmaceuticals USD 583K 148K Jun/2023
Merck USD 16.29B 110M Mar/2026
Northwest Biotherapeutics USD 200K 245K Sep/2025
Pfizer USD 14.5B 3.08B Mar/2026
Plus Therapeutics USD 1.37M 30K Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025